Table 6.3.

Names of antivirals recommended by the National Health Commission, People's Republic of China for the treatment of SARS-CoV-2.

Name of the drug	Dosage to be administered	Mode of administration
IFN-α	5 million units or equivalent, twice a day	Vapor inhalation
Lopinavir/ritonavir	200 mg/50 mg/capsule, 2 capsules each time twice a day	Oral
Ribavirin	500 mg in combination with IFN-α or lopinavir/ritonavir, 2–3 times a day	Intravenous infusion
Chloroquine phosphate	500 mg, 2 times a day	Oral
Chloroquine	300 mg, 2 times a day	Oral
Arbidol	200 mg each time, 3 times a day	Oral
The tenure of treatment is recommended for not more than 10 days.